IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $313,000 | +35.5% | 18,812 | +65.6% | 0.01% | +33.3% |
Q3 2017 | $231,000 | -18.1% | 11,359 | -49.1% | 0.01% | -33.3% |
Q1 2017 | $282,000 | -72.6% | 22,300 | -71.3% | 0.01% | -65.4% |
Q4 2016 | $1,028,000 | +167.0% | 77,612 | +378.2% | 0.03% | +188.9% |
Q3 2016 | $385,000 | -74.5% | 16,230 | -69.0% | 0.01% | -71.9% |
Q2 2016 | $1,510,000 | +67.2% | 52,408 | +85.8% | 0.03% | +39.1% |
Q1 2016 | $903,000 | -3.8% | 28,203 | +28.4% | 0.02% | -11.5% |
Q4 2015 | $939,000 | +116.9% | 21,963 | +78.6% | 0.03% | +73.3% |
Q3 2015 | $433,000 | +4.8% | 12,300 | +36.7% | 0.02% | +25.0% |
Q2 2015 | $413,000 | -5.3% | 9,000 | -3.2% | 0.01% | -14.3% |
Q1 2015 | $436,000 | -64.8% | 9,300 | -76.2% | 0.01% | -67.4% |
Q4 2014 | $1,237,000 | +41.5% | 39,050 | +6.0% | 0.04% | +34.4% |
Q3 2014 | $874,000 | +61.9% | 36,853 | +104.7% | 0.03% | +52.4% |
Q2 2014 | $540,000 | +13.4% | 18,000 | 0.0% | 0.02% | +5.0% |
Q1 2014 | $476,000 | +70.6% | 18,000 | +62.2% | 0.02% | +42.9% |
Q4 2013 | $279,000 | – | 11,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |